SCHEMBL7438334

SCHEMBL7438334

CC(C)CCC(O)C1(Cc2ccccc2)C[S+]([O-])CC(CO)(Cc2ccccc2)C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447857 0.79 ALDH1A1 (0.36)
SCHEMBL7440895 0.79 ALDH1A1 (0.36)
SCHEMBL7442024 0.64 MAOA (0.44)
SCHEMBL7442018 0.64 MAOA (0.44)
SCHEMBL7445686 0.61 MEN1 (0.31)
SCHEMBL7434413 0.61 MAOA (0.39)
SCHEMBL7444026 0.61 MAOA (0.39)
SCHEMBL7444576 0.59 LMNA (0.38)
SCHEMBL7439560 0.58 LMNA (0.31)
SCHEMBL27670530 0.55 HSD11B1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0641306-A1 CARBOCYCLIC AND HETEROCYCLIC HIV PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1995-03-08 EP claimed
WO-1992021647-A1 CARBOCYCLIC AND HETEROCYCLIC HIV PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1992-12-10 WO claimed
EP-0641306-A1 CARBOCYCLIC AND HETEROCYCLIC HIV PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1995-03-08 EP disclosed
WO-1992021647-A1 CARBOCYCLIC AND HETEROCYCLIC HIV PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1992-12-10 WO disclosed